Reinventing Drug Discovery, from Retrospective to Perspectives

10th NovAliX Conference - Anniversary Edition

 Brunnen, Switzerland    June 2-4, 2024

Programme


11:00

Registration

12:00

Welcome Lunch

13:30

Start of sessions

10th NovAliX Conference - DAY 1
10th NovAliX Conference - DAY 1
13:30
Opening & Welcome Address
Dr Jean-Paul RENAUD
URANIA THERAPEUTICS, Ostwald, France

SESSION 1 (Part 1):
Present and Future Tools for Drug Discovery
13:40
Introduction by session chair
13:45
The SGC over 20 Years: Open Experimental Data, Knowledge and Reagents Enabling Drug Discovery
Prof. Cheryl ARROWSMITH
STRUCTURAL GENOMICS CONSORTIUM, Toronto, Canada
14:25
Title of talk to be confirmed
Prof. Holger STARK
MAX PLANCK INSTITUTE FOR MULTIDISCIPLINARY SCIENCES, Göttingen, Germany
15:05
Coffee break & Exhibition

SESSION 2:
New Modalities as New Frontiers of Drug Discovery
15:35
Introduction by session chair
15:40
Biophysics for Protein Degraders: It’s all in the Ternary Complex
Prof. Alessio CIULLI
UNIVERSITY OF DUNDEE, Dundee, United Kingdom
16:20
Chance Favors the Perplexed Mind: The Critical Role of Biochemistry and Biophysics in the Development of Small Molecule Inhibitors of Chromatin- and RNA-Modifying Enzymes as Precision Cancer Therapeutics
Dr Robert COPELAND
ACCENT THERAPEUTICS, INC., Lexington, United States
17:00
Induced Proximity: Exploring New Therapeutic Modalities
Prof. Craig CREWS
YALE UNIVERSITY, New Haven, CT, United States
17:40
Round-table set-up
17:45
Round-table discussion: New Tools for New Modalities in Drug Discovery
18:30

End of the Day

19:00

Welcome Reception & Dinner

07:30

Breakfast

09:00

Start of sessions

10th NovAliX Conference - DAY 2
10th NovAliX Conference - DAY 2
SESSION 3:
Future Financing of Drug Discovery
09:00
Introduction by Session Chair
09:05
Title of talk to be announced
Mr Matthias BUCHER
CEPTON STRATEGIES, Paris, France
09:45
Title of talk to be announced
Mrs Magali RICHARD
HOME BIOSCIENCES, Paris, France
10:25
Coffee Break & Exhibition
10:55
Round-table discussion: Future Financing of Drug Discovery

SESSION 4 (Part 1):
Unmet Therapeutic Needs: Current Challenges
11:40
Introduction by Session Chair
11:45
Challenges and Opportunities in Cancer Therapy: a Perspective Across Modalities
Dr Tobias SCHMELZLE
NOVARTIS, Basel, Switzerland
12:25
Gene Therapy of Rare Diseases. A Quantum Leap in Medicine.
Dr Serge BRAUN
AFM TÉLÉTHON, Evry, France
13:05
Lunch & Networking

SESSION 1 (Part 2):
Present and Future Tools for Drug Discovery
14:40
Introduction by Session Chair
14:45
Title of talk to be announced
Dr Dave HALLETT
EXSCIENTIA LTD, Oxford, United Kingdom
15:25
Title of talk to be announced
Dr Maria M. FLOCCO
ASTRAZENECA, Cambridge, United Kingdom

SESSION 5 (Part 1):
Vision for the Future of Drug Discovery
16:05
Introduction by Session Chair
16:10
Title of talk to be announced - virtual lecture
Dr Frank LAUKIEN
BRUKER, Billerica, United States
Dr Falko BUSSE
BRUKER SWITZERLAND, Fällanden, Switzerland
16:50
Coffee Break & Exhibition
17:20
25 Years of Thinking Small
Dr Harren JHOTI
ASTEX PHARMACEUTICALS, Cambridge, United Kingdom
18:00
Adding Years of Life and Quality of Life: How the Healthcare Industry Can Bring Value to the World
Dr Paul STOFFELS
GALAPAGOS, Beerse, Belgium
18:40

End of the Day

18:45

Walking Tour around the Lake

19:30

Conference Dinner

07:30

Breakfast

09:00

Start of sessions

10th NovAliX Conference - DAY 3
10th NovAliX Conference - DAY 3
SESSION 4 (Part 2):
Unmet Therapeutic Needs: Current Challenges
09:00
Introduction by Session Chair
09:05
Keynote Speaker to be announced
09:45
Building a Pipeline of High-Impact Products to Prevent, Diagnose and Treat Bacterial Infections
Dr Erin DUFFY
CARB-X, Boston, United States
10:25
Coffee Break & Exhibition

SESSION 5 (Part 2):
Vision for the Future of Drug Discovery
10:55
Introduction by Session Chair
11:00
Round-table discussion: Vision for the Future of Drug Discovery
11:50
Title of talk to be announced
Dr Karin BRINER
GENENTECH, South San Francisco, United States
12:30
Title of talk to be announced
Dr Claude BERTRAND
INSTITUT DE RECHERCHES SERVIER, GIF-SUR-YVETTE, France
13:10
Closing Remarks
Dr Jean-Paul RENAUD
URANIA THERAPEUTICS, Ostwald, France
13:15

Closing Lunch & Departure